NECTIN4 and neoplasm: Patients with Nectin‐4‐positive tumours had significantly longer PFS, compared with those with Nectin‐4‐negative tumours (median PFS: 6.2 months vs. 1.4 months, respectively; p = 0.005, Figure 3A).